Multiple sclerosis is a chronic autoimmune disease that requires proactive early intervention and treatment to achieve the best long-term outcomes. But recommendations for MS patients who are pregnant can be murky.

Driven by knowledge gaps and concerns about the effects of disease-modifying therapies on the fetus, providers have often advised MS patients not to become pregnant. However, emerging research shows that patients can safely continue certain MS medications during pregnancy.

Katrina Bawden, a family nurse practitioner and MS-certified nurse at Rocky Mountain MS Clinic, is working to fill the research gap by tracking pregnancies among women with MS. She discusses the outcomes she is seeing with Senior Writer Anastassia Gliadkovskaya.

To learn more about the topics in this episode: 

• 'We want to feel heard': Jamie-Lynn Sigler on how pharmas can better serve patients
• As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study 
• Fewer than 1% of clinical trials in the US include pregnant patients, study finds